Press Releases


Central Indiana Racial Equity Fund Launches with more than $2.2 Million in Initial Commitments

June 25, 2020

Tags |  Corporate

The fund, established by the Eli Lilly and Company Foundation, Lumina Foundation and Central Indiana Community Foundation, will focus on solutions that address racial inequities in the criminal justice system INDIANAPOLIS , June 25, 2020 /PRNewswire/ -- A coalition of local stakeholders has




Eli Lilly and Company Foundation Pledges $25 Million to Combat Racial Injustice

June 13, 2020

Tags |  Corporate

Eli Lilly and Company commits 25,000 employee volunteer hours of service to help speed progress INDIANAPOLIS , June 13, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) and the Lilly Foundation announced today a pledge of $25 million and 25,000 volunteer hours over five years to decrease the




Lilly Partners with Indianapolis Recorder Newspaper, Radio One and WISH-TV for a Day of Solidarity Virtual Event

June 12, 2020

Tags |  Corporate

30-Minute Broadcasted Event on Saturday, June 13, at 12 p.m. EDT INDIANAPOLIS , June 12, 2020 /PRNewswire/ -- What: Eli Lilly and Company , Indianapolis Recorder Newspaper, Radio One and WISH-TV invite people and organizations to come together to acknowledge the trauma of racial injustice,




Lilly and Junshi Biosciences to Co-develop Antibody Therapies for the Prevention and Treatment of COVID-19

May 4, 2020

Tags |  Corporate

SHANGHAI and INDIANAPOLIS , May 4, 2020 /PRNewswire/ -- Junshi Biosciences (HKEX: 1877) and Eli Lilly and Company (NYSE: LLY) announced today they have entered into an agreement to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19, the disease caused by the




Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines

March 31, 2020

Tags |  Corporate

INDIANAPOLIS and OXFORD, England , March 31, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) today announced an exclusive global licensing and research collaboration with Sitryx, a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying therapeutics in




Lilly Provides Update on Clinical Trial Activities During COVID-19 Pandemic

March 23, 2020

Tags |  Corporate

INDIANAPOLIS , March 23, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) today provided an update on the company's clinical trial activities in light of the COVID-19 pandemic. The company will delay most new study starts and pause enrollment in most ongoing studies.




Lilly to Provide Drive-Through COVID-19 Testing for Indianapolis Health Care Workers

March 22, 2020

Tags |  Corporate

INDIANAPOLIS , March 22, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will offer drive-through testing for SARS-CoV-2, the virus that causes COVID-19, to Indianapolis area health care workers beginning Monday, March 23 , as a service to the community and in an effort to protect health care




Kathryn Beiser to join Lilly as Vice President, Global Communications

March 20, 2020

Tags |  Corporate

INDIANAPOLIS , March 20, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) announced today that Kathryn Beiser will join the company on April 6, 2020 as vice president, global communications. In this role, Beiser will oversee all aspects of the company's corporate communications strategy,




Lilly, Indiana State Department of Health Partner to Accelerate COVID-19 Testing Using Lilly Research Laboratories

March 18, 2020

Tags |  Corporate

INDIANAPOLIS , March 18, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE:LLY) announced today its scientists are partnering with the Indiana State Department of Health (ISDH), with support from the Food and Drug Administration (FDA), to accelerate testing in Indiana for SARS-CoV-2, the virus that




AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19

March 12, 2020

Tags |  Corporate

AbCellera and Lilly will select from 500+ unique antibodies isolated from one of the first U.S. patients who recovered from COVID-19 to create antibody therapeutics for treatment and prevention of COVID-19 VANCOUVER, British Columbia and INDIANAPOLIS , March 12, 2020 /PRNewswire/ -- AbCellera and